|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 215-218.
Prepublished online as a Blood First Edition Paper on June 10, 2004; DOI 10.1182/blood-2003-07-2367.
Previous Article | Next Article 
Submitted July 15, 2003
Accepted April 28, 2004
Platelet-associated CD154 in immune thrombocytopenic purpura
Anne Solanilla, Jean-Max Pasquet, Jean-Francois Viallard, Cecile Contin, Christophe Grosset, Julie Dechanet-Merville, Maryse Dupouy, Marc Landry, Francis Belloc, Paquita Nurden, Patrick Blanco, Jean-Francois Moreau, Jean-Luc Pellegrin, Alan Nurden, and Jean Ripoche*
CNRS FRE 2617, Universite de Bordeaux2, Bordeaux, France
Service de Medecine Interne, Hopital du Haut-Leveque, Pessac, France
UMR 5540, Universite de Bordeaux2, Bordeaux, France
Laboratoire d'Hematologie, Hopital Cardiologique, Pessac, France
* Corresponding author; email: Jean.Ripoche{at}umr5540.u-bordeaux2.fr.
CD40-ligand (CD154) is expressed on activated CD4+ T-lymphocytes and is essential for the T cell-dependent activation of B-lymphocytes. CD154 is also expressed at the activated platelet surface. In this study, we show that platelet-associated CD154 is increased in immune thrombocytopenic purpura (ITP), a disease characterized by an auto-immune response against proteins of the platelet membrane. CD154 and its messenger RNA were also present in increased amounts in the megakaryocytes of patients with ITP. We found that platelet-associated CD154 is competent to induce the CD40-dependent proliferation of B-lymphocytes and we observed an in vitro CD154-dependent production of antibodies to the GPIIb/IIIa complex (integrin IIb 3) when platelets and peripheral blood B lymphocytes from ITP patients with circulating anti-GPIIb/IIIa antibody were cultured together. Therefore, platelet-associated CD154 expression is increased in ITP and is able to drive the activation of auto-reactive B-lymphocytes in this disease.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. L. Sprague, B. D. Elzey, S. A. Crist, T. J. Waldschmidt, R. J. Jensen, and T. L. Ratliff
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles
Blood,
May 15, 2008;
111(10):
5028 - 5036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Elzey, N. W. Schmidt, S. A. Crist, T. P. Kresowik, J. T. Harty, B. Nieswandt, and T. L. Ratliff
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge
Blood,
April 1, 2008;
111(7):
3684 - 3691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Schallmoser, C Rosin, R Vormittag, M Brunner, D Dunkler, I Pabinger, and S Panzer
Specificities of Platelet Autoantibodies and Platelet Activation in Lupus Anticoagulant Patients: A Relation to their History of Thromboembolic Disease
Lupus,
August 1, 2006;
15(8):
507 - 514.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Elzey, J. F. Grant, H. W. Sinn, B. Nieswandt, T. J. Waldschmidt, and T. L. Ratliff
Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation
J. Leukoc. Biol.,
July 1, 2005;
78(1):
80 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |